Trade

Ganga Pharmaceuticals share price

Extreme risk
  • 180%Low risk
  • 180%Moderate risk
  • 180%Balanced risk
  • 180%High risk
  • 180%Extreme risk
  • 11.68(0.00%)
    November 20, 2025 16:00:01 PM IST
    • NSE
    • BSE
  • Vol : 0 (NSE + BSE)
    Last 20 day avg : 0

Ganga Pharmaceuticals is trading 0.00% upper at Rs 11.68 as compared to its last closing price. Ganga Pharmaceuticals has been trading in the price range of 0.00 & 0.00. Ganga Pharmaceuticals has given 0.00% in this year & 0.00% in the last 5 days. The company posted a net profit of 0.02 Crores in its last quarter.Listed peers of Ganga Pharmaceuticals include Sun Pharmaceutical Industries (-0.12%), Dr Reddy's Laboratories (-0.98%), Torrent Pharmaceuticals (-0.50%).The Mutual Fund holding in Ganga Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Ganga Pharmaceuticals was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 21, 2026, 04:28 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
0.00
Highest
0.00
52 week range
Lowest
9.25
Highest
17.59
Ganga Pharmaceuticals Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bearish
1,610.10-0.123,86,307.8236.245.770.920.50
Dr Reddy's Laboratories
Bearish
1,155.50-0.9896,437.0318.633.140.632.34
Torrent Pharmaceuticals
Bullish
3,955.00-0.501,33,849.8067.3217.10.8317.62
Cipla
Bearish
1,369.55-0.601,11,043.4422.953.870.870.81
Divi's Laboratories
Bearish
6,004.65-0.081,59,494.1978.6111.520.460.01
Ganga Pharmaceuticals Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-07Half Yearly Results
2025-05-20Audited Results
2024-11-08Half Yearly Results
2024-05-16Audited Results
2023-12-04Preferential issue of shares
About the company Ganga Pharmaceuticals
  • IndustryBiotechnology & Drugs
  • ISININE615T01017
  • BSE Code539680
  • NSE Code
Ganga Pharmaceuticals Limited is an India-based company. The Company is engaged in the production of ayurvedic medicine. Apart from manufacturing, the Company is also into marketing and distribution of ayurvedic medicines. It offers ayurvedic medicines for acidity, antidandruff, antioxidants, blood purifier and skin disorder, constipation, cough and cold, dental care, diarrhea, ear care, female tonic, hair care, hemorrhoids and piles, indigestion, iron tonic, joint pains, kidney stone, liver disorder, rejuvenation tonic, sleep inducers, and offers herbal cosmetics. Its products include Asuka tablets, Dendroil, Ashwo tablets-tonic for body and mind; Raktaj tablets/syrup for skin disorders; Nirmalaya that relieves constipation; Khadira tablets (80 mg.) that relieves cough; Danta Doshahar Manjan for gum and teeth protective; Holetrica capsule that checks diarrhea and corrects digestion; Karnaraj drops ear drops, Femoherb syrup/tablets, and Mahabhrungraj oil.
  • Management Info
  • Sanjay KulkarniNon-Executive Chairman of the Board
  • Bharat SharmaChief Executive Officer, Managing Director, Executive Director
  • Anagh SharmaChief Financial Officer
  • Priti BhaiyaCompliance Officer, Company Secretary
  • Srijna SharmaWhole Time Director
Ganga Pharmaceuticals Share Price FAQs

Ganga Pharmaceuticals is trading at 11.68 as on Thu Nov 20 2025 10:30:01. This is 0.00% upper as compared to its previous closing price of 11.68.

The market capitalization of Ganga Pharmaceuticals is 6.90 Cr as on Thu Nov 20 2025 10:30:01.

The 52 wk high for Ganga Pharmaceuticals is 17.59 whereas the 52 wk low is 9.25

Ganga Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: -
  • Dividend Yield: 0.00%
  • D/E ratio: 0.19

Ganga Pharmaceuticals reported a net profit of 0.08 Cr in 2025.